Comparable stake leader
Ivana Magovcevic-Liebisch
SEC ownership of APPLIED GENETIC TECHNOLOGIES CORP
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001273636.
Disclosed value leader
—
Comparable rows
0/1
Latest evidence
30 Nov 2021
- Parsed ownership sources
- 3/4/5
- Largest SEC-reported holder
- Ivana Magovcevic-Liebisch
- Latest parsed ownership date
- 30 Nov 2021
- Issuer CIK
- 0001273636
- Issuer location
- Alachua, FL
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of APPLIED GENETIC TECHNOLOGIES CORP (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ivana Magovcevic-Liebisch
Disclosed value leader
—
Comparable rows
0/1
Latest evidence
30 Nov 2021
3/4/5
Some rows are evidence-backed but not safely comparable across classes.
1 rows are not safely comparable across share classes.
Quick read
SEC ownership evidence is available, but the rows are not safely comparable across share classes.
0 of 1 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ivana Magovcevic-Liebisch's linked filing trail.
Detailed SEC evidence table Showing 1-1 of 1 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ivana Magovcevic-Liebisch |
3/4/5
Director
|
—
class O/S missing
|
—
14,000 shares
|
— | 30 Nov 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 10 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-15 of 15 reporting-owner rows connected to APPLIED GENETIC TECHNOLOGIES CORP. Open a relationship link for the CIK-to-CIK filing trail.
Rows
15
Largest Forms 3/4/5 holder
William Aliski
Net 12M change
$0
Latest report
30 Nov 2022
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| William Aliski | Director | Mixed | 30 Nov 2022 | |||
| Scott Koenig | Director | Mixed | 30 Nov 2022 | |||
| Gerald Anthony Reynolds | Chief Accounting Officer | Mixed | 30 Nov 2022 | |||
| Stephen W. Potter | Chief Business Officer | Mixed | 30 Nov 2022 | |||
| Susan B. Washer | President and CEO, Director | Mixed | 30 Nov 2022 | |||
| Jonathan I. Lieber | Chief Financial Officer | Mixed | 30 Nov 2022 | |||
| Abraham Scaria | Chief Scientific Officer | Mixed | 30 Nov 2022 | |||
| Hope DOyley-Gay | General Counsel | Mixed | 30 Nov 2022 | |||
| Anne Vanlent | Director | Mixed | 30 Nov 2022 | |||
| Yehia Hashad | Director | Mixed | 30 Nov 2022 | |||
| Susan Schneider | Chief Medical Officer | Mixed | 30 Nov 2022 | |||
| James A. Robinson Jr. | Director | Mixed | 30 Nov 2022 | |||
| Edward Hurwitz | Director | Mixed | 30 Nov 2022 | |||
| Ivana Magovcevic-Liebisch | Director | Mixed | 30 Nov 2021 | |||
| James Rosen | Director | Mixed | 30 Nov 2022 |
Recent insider transactions for APPLIED GENETIC TECHNOLOGIES CORP
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.